Deferred Income Tax Expense (Benefit) in USD of PFIZER INC from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Pfizer Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2025.
  • Pfizer Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 30, 2025 was -$663M, a 50.3% decline year-over-year.
  • Pfizer Inc annual Deferred Income Tax Expense (Benefit) for 2024 was -$2.1B, a 38.9% increase from 2023.
  • Pfizer Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$3.44B, a 8.56% increase from 2022.
  • Pfizer Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$3.76B, a 12.3% increase from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

PFIZER INC Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$663M -$222M -50.3% Jan 1, 2025 Mar 30, 2025 10-Q 2025-05-05
Q1 2024 -$441M +$157M +26.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 -$598M +$1.72B +74.2% Jan 1, 2023 Apr 2, 2023 10-Q 2024-05-08
Q1 2022 -$2.32B -$2.52B -1243% Jan 1, 2022 Apr 3, 2022 10-Q 2023-05-10
Q1 2021 $203M +$121M +148% Jan 1, 2021 Apr 4, 2021 10-Q 2022-05-11
Q1 2020 $82M +$142M Jan 1, 2020 Mar 29, 2020 10-Q 2021-05-13
Q1 2019 -$60M -$354M -120% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $294M +$256M +674% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-09
Q1 2017 $38M +$242M Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-10
Q1 2016 -$204M -$163M -398% Jan 1, 2016 Apr 3, 2016 10-Q 2017-05-11
Q1 2015 -$41M -$386M -112% Jan 1, 2015 Mar 29, 2015 10-Q 2016-05-12
Q1 2014 $345M -$575M -62.5% Jan 1, 2014 Mar 30, 2014 10-Q 2015-05-07
Q1 2013 $920M +$1.32B Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 -$396M -$276M -230% Jan 1, 2012 Apr 1, 2012 10-Q 2013-05-10
Q1 2011 -$120M -$960M -114% Jan 1, 2011 Apr 3, 2011 10-Q 2012-05-10
Q1 2010 $840M Jan 1, 2010 Apr 4, 2010 10-Q 2011-05-12

PFIZER INC Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2.1B +$1.34B +38.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$3.44B +$322M +8.56% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$3.76B +$529M +12.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$4.29B -$2.72B -173% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$1.58B -$2.14B -381% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $561M +$2.77B Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$2.2B +$206M +8.55% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$2.41B -$1.71B -244% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$700M -$680M -3400% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$20M -$340M -106% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $320M -$1.41B -81.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $1.73B +$940M +120% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $786M +$550M +233% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $236M -$1.87B -88.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $2.11B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.